The investigation on the modulations of lipid receptors will impact on the potential importance of S1P2, S1P5, LPA1, LPA2, LPA6, P2Y10, GPR174, EP1, DP1, DP2, IP, FP, and TXA2r as a target for AD. This evidence concerns the gene GPR174 and Alzheimer disease.